267 related articles for article (PubMed ID: 21034488)
1. Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment.
Capriles PV; Guimarães AC; Otto TD; Miranda AB; Dardenne LE; Degrave WM
BMC Genomics; 2010 Oct; 11():610. PubMed ID: 21034488
[TBL] [Abstract][Full Text] [Related]
2. In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.
Lima CR; Carels N; Guimaraes AC; Tufféry P; Derreumaux P
J Mol Model; 2016 Oct; 22(10):244. PubMed ID: 27665464
[TBL] [Abstract][Full Text] [Related]
3. The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas disease.
Lisvane Silva P; Mantilla BS; Barisón MJ; Wrenger C; Silber AM
Curr Pharm Des; 2011; 17(20):2074-99. PubMed ID: 21718252
[TBL] [Abstract][Full Text] [Related]
4. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
[TBL] [Abstract][Full Text] [Related]
5. Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.
D'Antonio EL; Deinema MS; Kearns SP; Frey TA; Tanghe S; Perry K; Roy TA; Gracz HS; Rodriguez A; D'Antonio J
Mol Biochem Parasitol; 2015 Dec; 204(2):64-76. PubMed ID: 26778112
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and bioinformatic analysis of Trypanosoma cruzi chemotherapy and potential drug targets: new pieces for an old puzzle.
Sadok Menna-Barreto RF; Belloze KT; Perales J; Silva FP
Curr Drug Targets; 2014 Mar; 15(3):255-71. PubMed ID: 24041335
[TBL] [Abstract][Full Text] [Related]
7.
Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
[TBL] [Abstract][Full Text] [Related]
8. A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection.
Doyle PS; Chen CK; Johnston JB; Hopkins SD; Leung SS; Jacobson MP; Engel JC; McKerrow JH; Podust LM
Antimicrob Agents Chemother; 2010 Jun; 54(6):2480-8. PubMed ID: 20385875
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of the Secretome and Interactome of
Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
Front Immunol; 2020; 11():1774. PubMed ID: 32973747
[TBL] [Abstract][Full Text] [Related]
10. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
[TBL] [Abstract][Full Text] [Related]
11. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
[TBL] [Abstract][Full Text] [Related]
12. In silico reconstruction of the amino acid metabolic pathways of Trypanosoma cruzi.
Guimarães AC; Otto TD; Alves-Ferreira M; Miranda AB; Degrave WM
Genet Mol Res; 2008 Sep; 7(3):872-82. PubMed ID: 18949706
[TBL] [Abstract][Full Text] [Related]
13. Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Zuccotto F; Zvelebil M; Brun R; Chowdhury SF; Di Lucrezia R; Leal I; Maes L; Ruiz-Perez LM; Gonzalez Pacanowska D; Gilbert IH
Eur J Med Chem; 2001 May; 36(5):395-405. PubMed ID: 11451529
[TBL] [Abstract][Full Text] [Related]
14. Gene identification and comparative molecular modeling of a Trypanosoma rangeli major surface protease.
Calixto PH; Bitar M; Ferreira KA; Abrahão O; Lages-Silva E; Franco GR; Ramírez LE; Pedrosa AL
J Mol Model; 2013 Aug; 19(8):3053-64. PubMed ID: 23584556
[TBL] [Abstract][Full Text] [Related]
15. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
Maluf FV; Andricopulo AD; Oliva G; Guido RV
Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi Invasion into Host Cells: A Complex Molecular Targets Interplay.
Campo VL; Martins-Teixeira MB; Carvalho I
Mini Rev Med Chem; 2016; 16(13):1084-97. PubMed ID: 27281167
[TBL] [Abstract][Full Text] [Related]
18. Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2.
Marek M; Ramos-Morales E; Picchi-Constante GFA; Bayer T; Norström C; Herp D; Sales-Junior PA; Guerra-Slompo EP; Hausmann K; Chakrabarti A; Shaik TB; Merz A; Troesch E; Schmidtkunz K; Goldenberg S; Pierce RJ; Mourão MM; Jung M; Schultz J; Sippl W; Zanchin NIT; Romier C
Cell Rep; 2021 Dec; 37(12):110129. PubMed ID: 34936867
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients.
Skeiky YA; Benson DR; Parsons M; Elkon KB; Reed SG
J Exp Med; 1992 Jul; 176(1):201-11. PubMed ID: 1377223
[TBL] [Abstract][Full Text] [Related]
20. Chagas disease: a homology model for the three-dimensional structure of the Trypanosoma cruzi ribosomal P0 antigenic protein.
Gomez Barroso JA; Aguilar CF
Eur Biophys J; 2014 Sep; 43(8-9):361-6. PubMed ID: 24986473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
